Entries Tagged 'Cancer News' ↓

Widely used biomarkers are not optimal in early detection of liver cancer, the third most common cause of cancer-related death worldwide, according to a new study published in this month’s Gastroenterology.

Kinex Pharmaceuticals opened a Phase 2 clinical trial to evaluate the safety and efficacy of KX2- 391 in patients with bone-metastatic, castrate- resistant prostate cancer (CRPC) who have not had prior chemotherapy.

Bright red and juicy, cherry tomatoes are usually tossed into salads, eaten out of hand as a snack or used for a cheery garnish. But there’s no reason you can’t work the tiny tomatoes into a savory side dish.

The message is a simple one: Colorectal cancer is preventable, treatable and beatable IF you get screened to catch the disease early, and if you eat a rainbow of foods rich in cancer- fighting nutrients and fiber and lead a lively lifestyle, incorporating exercise and a positive outlook.

Researchers have found that one particularly aggressive type of blood cancer, mixed lineage leukemia (MLL), has an unusual way to keep the molecular motors running. The cancer cells rely on the normal version of an associated protein to stay alive.

Neurosurgeons at Allegheny General Hospital (AGH) are exploring use of a drug that illuminates brain tumor cells to determine if the experimental visualization technique will enhance their ability to surgically excise tumors and improve patient survival.

The U.S. Food and Drug Administration today approved a risk management program to inform healthcare providers and their patients about the risks of a class of drugs called Erythropoiesis-Stimulating Agents (ESAs). For patients with cancer, the program is also designed to help ensure the appropriate administration of these drugs, which they receive to treat anemia that can occur as a result of chemotherapy.

Calypso Medical Technologies, Inc., a developer of targeting technology used for accurate, precise real-time tracking of tumor targets, today announced the online publication of a clinical study in Urology (The GOLD JOURNAL). The prospective, multi-site study, entitled, “Assessing the Impact of Margin Reduction (AIM),” is the first outcomes-based study to evaluate the quality of life of high-dose intensity-modulated radiotherapy (IMRT) to the prostate with tightly contoured treatment technically described as “reduced treatment margins.” The study findings demonstrate that the use of the Calypso System during high dose external beam radiation for prostate cancer resulted in a significant reduction in rectal and urinary treatment-related side effects.

Investigators publish new data in the report ‘Should the use of contralateral prophylactic mastectomy be increasing as it is.’ Recent studies have shown a dramatic increase in the use of contralateral prophylactic mastectomy (CPM). The choice of surgical procedure is primarily influenced by the recommendations of physicians and surgeons, scientists in the United States report.

US experts called Friday for toxicity tests on chemicals they suspect play a role in the development of breast cancer, a leading cause of death in American women. We’re currently not identifying chemicals that could be contributing to the risk of breast cancer, said Megan Schwarzman, a physician and environmental health researcher at the University of California, Berkeley.

Nearly half the people who need potentially lifesaving checks for colorectal cancer miss them, despite years of public effort in the United States to make colon screening as widespread as tests for breast and prostate cancer.

According to recent research from the United States, Intestinal microbes have been postulated to play an important role in the development of colorectal cancer. Recently developed methods for preserving and delivering fecal samples at ambient temperature to the laboratory for molecular analysis of bacterial constituents were used to test associations of bacterial populations with epidemiologic risk factors for colorectal cancer.

Tumor-host interaction at the invasive front of colorectal cancer represents a critical interface encompassing a dynamic process of de- differentiation of colorectal carcinoma cells known as epithelial mesenchymal transition (EMT). EMT can be identified histologically by the presence of tumor budding, a feature which can be highly specific for tumors showing an infiltrating tumor growth pattern, scientists in Basel, Switzerland report.

A common antidepressant weakens or cancels the beneficial effects of a standard treatment for breast cancer, according to a study released Tuesday. Women who take the mood drug paroxetine — better known by its brand names Paxil and Seroxat — at the same time as the breast cancer medication tamoxifen face an increased risk of death, researchers reported.

More bad news for soda-drinkers: A University of Minnesota study suggests that drinking two or more soft drinks a week nearly doubles the risk of developing pancreatic cancer. Mark Pereira, an associate professor at the School of Public Health, and his research team studied the dietary habits of more than 60,000 adults in Singapore for 14 years.

Current study results from the report, ‘Feasibility and safety of radiofrequency ablation for locally advanced pancreatic cancer,’ have been published. Radiofrequency ablation (RFA) may be a valuable treatment option for locally advanced pancreatic cancer. The present study examined its feasibility and safety, researchers in Verona, Italy report.